Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.705 USD | -0.11% | +5.39% | -6.39% |
05:57pm | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
05-15 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.39% | 187M | |
+33.03% | 49.46B | |
+1.41% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.70% | 26.61B | |
-22.68% | 18.64B | |
+8.35% | 13.16B | |
+29.30% | 12.55B | |
+24.30% | 12.1B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $22 From $15, Reiterates Overweight Rating